Finnrick - Ensuring a Safer and More Transparent Supply Chain
Steady Meds

Steady Meds

Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Steady Meds between 25 Feb 2026 and 6 Mar 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
Tentative Rating
Steady Meds
Tirzepatide
Tested 4 Samples
Last test 6 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Steady Meds

Samples are tested in commercial labs

Tests Count

4

Scores

AVG6.8MIN5.3MAX7.9

Last

6 Mar 2026

First

25 Feb 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
6 Mar 2026View6.160mg53.1mg-11.5%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
6 Mar 2026View5.330mg24.6mg-18.0%99.90%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
25 Feb 2026View7.930mg31mg+3.3%99.87%(no batch ID)No Label / Silver Crimp / Gray CapLab EPublic
25 Feb 2026View7.860mg60.3mg+0.5%99.82%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
Test my peptides for free